Drug intelligence / Profile preview

HinTCAR2019

Development stage
Unknown
Lead developer
Tongji Hospital
Modality
CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
Administration
Intravenous
01

Overview

HinTCAR2019 is a hinge-optimized, tandem bispecific chimeric antigen receptor (CAR) T-cell therapy targeting both CD19 and CD20 antigens. Developed to address antigen escape in patients with relapsed or refractory B-cell lymphoma (r/r BCL), the construct features a minimal hinge optimization—specifically a short "AS" motif between the scFv and hinge domain—which enhances CAR surface expression and cytotoxic potency compared to earlier dual CAR constructs. Clinical data from a Phase Ia/Ib study (NCT05388695) indicates a favorable safety profile and durable efficacy, particularly when used in a sequential strategy followed by autologous stem cell transplantation (ASCT) consolidation.

Other names
tandem CD19/CD20 CAR-Thinge-optimized tandem CD19/CD20 CAR T-cell therapy
02

Targets

Beyond the preview

Go deeper on HinTCAR2019.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HinTCAR2019.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call